AQR Capital Management
CAPR icon

AQR Capital Management’s Capricor Therapeutics CAPR Stock Holding History

AQR Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Buy
10,022
+1,426
+17% +$38K ﹤0.01% 3399
2025
Q4 		$248K Sell
8,596
-3,765
-30% -$49.2K ﹤0.01% 3259
2025
Q3 		$89.1K Buy
+12,361
New +$91K ﹤0.01% 3377
2025
Q1 		– Sell
-11,097
Closed -$153K – 3158
2024
Q4 		$153K Sell
11,097
-28,519
-72% -$500K ﹤0.01% 2713
2024
Q3 		$603K Buy
+39,616
New +$196K ﹤0.01% 2081

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AQR Capital Management's CAPR Position: Q1 2026 in Review

AQR Capital Management increased its Capricor Therapeutics (CAPR) stake by 17% in Q1 2026, buying an estimated $38K and bringing the position to 10,022 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

AQR Capital Management first reported a position in CAPR in Q3 2024 and has held it in 5 quarters since. The position peaked at $603K in Q3 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • AQR Capital Management held 10,022 shares of Capricor Therapeutics worth $305K as of Q1 2026.
  • AQR Capital Management bought 1,426 Capricor Therapeutics shares in Q1 2026, an estimated $38K.
  • Capricor Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3399 holding.
  • AQR Capital Management first reported a position in Capricor Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • AQR Capital Management's Capricor Therapeutics position peaked at $603K in Q3 2024.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.